Bridging the organoid translational gap: integrating standardization and micropatterning for drug screening in clinical and pharmaceutical medicine

Abstract

Synthetic organ models such as organoids and organ-on-a-chip have been receiving recognition from administrative agencies. Despite the proven success of organoids in predicting drug efficacy on laboratory scales, their translational advances have not fully satisfied the expectations for both clinical implementation and commercial applications. The transition from laboratory settings to clinical applications continues to encounter challenges. Employing engineering methodologies to facilitate the bridging of this gap for organoids represents one of the key directions for future advancement. The main measures to bridge the gap include environmental and phenotypic recapitulation, 3D patterning, matrix engineering, and multi-modality information acquisition and processing. Pilot whole-process clinical/pharmaceutical applications with fast and standardized organoid models will continuously offer convincing frontline optimization clues and driving forces to the organoid community, which is a promising path to translational organoid technologies.

Keywords

organoid / organoid micropatterning / organoid standardization / organoids-on-a-chip

References

[1] Hofer M , Lutolf MP . Engineering organoids. Nat Rev Mater 2021; 6: 402- 20.

[2] Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646- 74.

[3] Rishton GM . Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations. Med Chem 2005; 1: 519- 27.

[4] Drews J . Drug discovery: a historical perspective. Science 2000; 287: 1960- 4.

[5] Kinch MS . An overview of FDA-approved biologics medicines. Drug Discov Today 2015; 20: 393- 8.

[6] Loewa A , Feng JJ , Hedtrich S . Human disease models in drug development. Nat Rev Bioeng 2023; 1: 545- 59.

[7] Tang XY , Wu S , Wang D , et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther 2022; 7: 168.

[8] Lee H , Im JS , Choi DB , et al. Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids. Organoid 2021; 1: e11.

[9] Tuveson D , Clevers H . Cancer modeling meets human organoid technology. Science 2019; 364: 952- 5.

[10] Sato T , Vries RG , Snippert HJ , et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459: 262- 5.

[11] Dijkstra KK , Monkhorst K , Schipper LJ , et al. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Reports 2020; 31: 107588.

[12] Yin S , Xi R , Wu A , et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med 2020; 12: eaaz1723.

[13] Li L , Su H , Ji Y , et al. Deciphering cell-cell interactions with integrative singlecell secretion profiling. Adv Sci 2023; 10: 2301018.

[14] Han Y , Duan X , Yang L , et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature 2021; 589: 270- 5.

[15] Si L , Bai H , Rodas M , et al. A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng 2021; 5: 815- 29.

[16] Brandenberg N , Hoehnel S , Kuttler F , et al. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays. Nat Biomed Eng 2020; 4: 863- 74.

[17] Tran T , Song CJ , Nguyen T , et al. A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery. Cell Stem Cell 2022; 29: 1083- 101.e7.

[18] Ding S , Hsu C , Wang Z , et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell 2022; 29: 905- 17.e6.

[19] Jiang S , Zhao H , Zhang W , et al. An automated organoid platform with inter-organoid homogeneity and inter-patient heterogeneity. Cell Reports Med 2020; 1: 100161.

[20] Lawlor KT , Vanslambrouck JM , Higgins JW , et al. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation. Nat Mater 2021; 20: 260- 71.

[21] Brassard JA , Nikolaev M , Hübscher T , et al. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat Mater 2021; 20: 22- 9.

[22] Roth JG , Brunel LG , Huang MS , et al. Spatially controlled construction of assembloids using bioprinting. Nat Commun 2023; 14: 4346.

[23] Hsiao AY , Tung Y-C , Qu X , et al. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids. Biotechnol Bioeng 2012; 109: 1293- 304.

[24] Moragues T , Arguijo D , Beneyton T , et al. Droplet-based microfluidics. Nat Rev Methods Primers 2023; 3: 32.

[25] Gjorevski N , Nikolaev M , Brown TE , et al. Tissue geometry drives deterministic organoid patterning. Science 2022; 375: eaaw9021.

[26] Park SE , Kang S , Paek J , et al. Geometric engineering of organoid culture for enhanced organogenesis in a dish. Nat Methods 2022; 19: 1449- 60.

[27] Cao Y , Tan J , Zhao H , et al. Bead-jet printing enabled sparse mesenchymal stem cell patterning augments skeletal muscle and hair follicle regeneration. Nat Commun 2022; 13: 7463.

[28] Ayan B , Heo DN , Zhang Z , et al. Aspiration-assisted bioprinting for precise positioning of biologics. Sci Adv 2020; 6: eaaw5111.

[29] Neal JT , Li X , Zhu J , et al. Organoid modeling of the tumor immune microenvironment. Cell 2018; 175: 1972- 88.e16.

[30] Raghavan S , Winter PS , Navia AW , et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 2021; 184: 6119- 37.e26.

[31] Seino T , Kawasaki S , Shimokawa M , et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell 2018; 22: 454- 67.e6.

[32] Li Y , Chen M , Hu J , et al. Volumetric compression induces intracellular crowding to control intestinal organoid growth via Wnt/beta-Catenin Signaling. Cell Stem Cell 2021; 28: 63- 78.e7.

[33] Hughes CS , Postovit LM , Lajoie GA . Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 2010; 10: 1886- 90.

[34] Nguyen EH , Daly WT , Le NNT , et al. Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion. Nat Biomed Eng 2017; 1: 0096.

[35] Kechagia JZ , Ivaska J , Roca-Cusachs P . Integrins as biomechanical sensors of the microenvironment. Nat Rev Mol Cell Biol 2019; 20: 457- 73.

[36] Barnes JM , Przybyla L , Weaver VM . Tissue mechanics regulate brain development, homeostasis and disease. J Cell Sci 2017; 130: 71- 82.

[37] Dennis JW , Laferté S , Waghorne C , et al. β1-6 branching of Asnlinked oligosaccharides is directly associated with metastasis. Science 1987; 236: 582- 5.

[38] DuFort CC , Paszek MJ , Weaver VM . Balancing forces: architectural control of mechanotransduction. Nat Rev Mol Cell Biol 2011; 12: 308- 19.

[39] Pathak MM , Nourse JL , Tran T , et al. Stretch-activated ion channel Piezo1 directs lineage choice in human neural stem cells. Proc Natl Acad Sci USA 2014; 111: 16148- 53.

[40] Prince E , Cruickshank J , Ba-Alawi W , et al. Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids. Nat Commun 2022; 13: 1466.

[41] Hunt DR , Klett KC , Mascharak S , et al. Engineered matrices enable the culture of human patient-derived intestinal organoids. Adv Sci 2021; 8: 2004705.

[42] Chrisnandy A , Blondel D , Rezakhani S , et al. Synthetic dynamic hydrogels promote degradation-independent in vitro organogenesis. Nat Mater 2022; 21: 479- 87.

[43] Sorrentino G , Rezakhani S , Yildiz E , et al. Mechano-modulatory synthetic niches for liver organoid derivation.Nat Commun 2020; 11: 3416.

[44] Beghin A , Grenci G , Sahni G , et al. Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification. Nat Methods 2022; 19: 881- 92.

[45] Czerniecki SM , Cruz NM , Harder JL , et al. High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping. Cell Stem Cell 2018; 22: 929- 40.e4.

[46] Artegiani B , Hendriks D , Beumer J , et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat Cell Biol 2020; 22: 321- 31.

[47] Scholler J , Groux K , Goureau O , et al. Dynamic full-field optical coherence tomography: 3D live-imaging of retinal organoids. Light: Sci Appl 2020; 9: 140.

[48] Haja A , Horcas-Nieto JM , Bakker BM , et al. Towards automatization of organoid analysis: a deep learning approach to localize and quantify organoid images. Comp Methods Progr Biomed Update 2023; 3: 100101.

[49] Larsen BM , Kannan M , Langer LF , et al. A pan-cancer organoid platform for precision medicine. Cell Reports 2021; 36: 109429.

[50] Fan J , Feng Y , Cheng Y , et al. Multiplex gene quantification as digital markers for extremely rapid evaluation of chemo-drug sensitivity. Patterns 2021; 2: 100360.

[51] Chen Z , Ma N , Sun X , et al. Automated evaluation of tumor spheroid behavior in 3D culture using deep learning-based recognition. Biomaterials 2021; 272: 120770.

[52] Gritti N , Lim Jia Le , Anlaş K , et al. MOrgAna: accessible quantitative analysis of organoids with machine learning. Development 2021; 148: dev199611.

[53] Park SE , Georgescu A , Huh D . Organoids-on-a-chip. Science 2019; 364: 960- 5.

[54] Yu F , Hunziker W , Choudhury D . Engineering microfluidic organoidon-a-chip platforms. Micromachines 2019; 10: 165.

[55] Karzbrun E , Kshirsagar A , Cohen SR , et al. Human brain organoids on a chip reveal the physics of folding. Nat Phys 2018; 14: 515- 22.

[56] Matsumoto M , Morimoto Y , Sato T , et al. Microfluidic device to manipulate 3D human epithelial cell-derived intestinal organoids. Micromachines 2022; 13: 2082.

[57] Zhao X , Hu J , Li Y , et al. Volumetric compression develops noise-driven single-cell heterogeneity. Proc Natl Acad Sci USA 2021; 118: e2110550118.

[58] Schuster B , Junkin M , Kashaf SS , et al. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat Commun 2020; 11: 5271.

[59] Tao T , Deng P , Wang Y , et al. Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet axis in normal and type 2 diabetes. Adv Sci 2022; 9: e2103495.

[60] Kroll KT , Mata MM , Homan KA , et al. Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies. Proc Natl Acad Sci USA 2023; 120: e2305322120.

[61] Homan KA , Gupta N , Kroll KT , et al. Flow-enhanced vascularization and maturation of kidney organoids in vitro. Nat Methods 2019; 16: 255- 62.

[62] Hu Z , Cao Y , Galan EA , et al. Vascularized tumor spheroid-on-achip model verifies synergistic vasoprotective and chemotherapeutic effects. ACS Biomater Sci Eng 2022; 8: 1215- 25.

[63] Huh D , Matthews BD , Mammoto A , et al. Reconstituting organ-level lung functions on a chip. Science 2010; 328: 1662- 8.

RIGHTS & PERMISSIONS

2024 The Author(s) 2024. Published by Oxford University Press on behalf of Higher Education Press.